Advanced search
Publication Cover
Psychosis
Psychological, Social and Integrative Approaches
Volume 2, 2010 - Issue 1
Submit an article Journal homepage
300
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Antipsychotic medication, mortality and neurodegeneration: The need for more selective use and lower doses

Stefan Weinmann Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medicine Berlin, GermanyCorrespondence[email protected]
&
Volkmar Aderhold Institute of Social Psychiatry, Department of Psychiatry, University of Greifswald, Germany
Pages 50-69 | Received 12 May 2009, Accepted 21 Nov 2009, Published online: 10 Dec 2009

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

John Read. (2022) How important are informed consent, informed choice, and patient-doctor relationships, when prescribing antipsychotic medication?. Journal of Mental Health 0:0, pages 1-9.
Read now
Dirk Corstens, Eleanor Longden, Bertel Rydinger, Richard Bentall & Jim van Os. (2013) Treatment of hallucinations: A comment. Psychosis 5:1, pages 98-102.
Read now
Professor Richard Bentall & Professor Tony Morrison. (2011) Letter to the editor. Psychosis 3:2, pages 177-178.
Read now
Warren Larkin & Max Marshall. (2010) DSM‐5 and the ‘Psychosis Risk Syndrome’: no different than any other diagnostictest. Psychosis 2:3, pages 191-195.
Read now
ColinA. Ross. (2010) DSM‐5 and the ‘Psychosis Risk Syndrome’: Eight reasons to reject it. Psychosis 2:2, pages 107-110.
Read now
AnthonyP. Morrison, Rory Byrne & RichardP. Bentall. (2010) DSM‐5 and the ‘Psychosis Risk Syndrome’: Whose best interests would it serve?. Psychosis 2:2, pages 96-99.
Read now

Articles from other publishers (9)

Marsha Maredia, John Hamilton & Panayotis K. Thanos. (2021) A high-fat diet, but not haloperidol or olanzapine administration, increases activated microglial expression in the rat brain. Neuroscience Letters 757, pages 135976.
Crossref
Daniela Rodrigues-Amorim, Tania Rivera-Baltanás, María del Carmen Vallejo-Curto, Cynthia Rodriguez-Jamardo, Elena de las Heras, Carolina Barreiro-Villar, María Blanco-Formoso, Patricia Fernández-Palleiro, María Álvarez-Ariza, Marta López, Alejandro García-Caballero, José Manuel Olivares & Carlos Spuch. (2020) Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia. Scientific Reports 10:1.
Crossref
John Read & Ann Sacia. (2020) Using Open Questions to Understand 650 People’s Experiences With Antipsychotic Drugs. Schizophrenia Bulletin 46:4, pages 896-904.
Crossref
John Read & James Williams. (2019) Positive and Negative Effects of Antipsychotic Medication: An International Online Survey of 832 Recipients. Current Drug Safety 14:3, pages 173-181.
Crossref
Gabrielle Le Geyt, Yvonne Awenat, Sara Tai & Gillian Haddock. (2016) Personal Accounts of Discontinuing Neuroleptic Medication for Psychosis. Qualitative Health Research 27:4, pages 559-572.
Crossref
John Read, Olga Runciman & Jacqui Dillon. (2016) In search of an evidence-based role for psychiatry. Future Science OA 2:1.
Crossref
Marc WH Lochmann van Bennekom, Harm J Gijsman & Frans G Zitman. (2013) Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness. Journal of Psychopharmacology 27:4, pages 327-336.
Crossref
Daniel Skehan, Warren Larkin & John Read. (2012) Childhood adversity and psychosis: A literature review with clinical and societal implications. Psychoanalysis, Culture & Society 17:4, pages 373-391.
Crossref
Stefan Weinmann, Volkmar Aderhold & John Read. (2011) Antipsychotic medication and mortality: A clarification. Schizophrenia Research 133:1-3, pages 261.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.